Simonneau, Gérald <br/><br/>
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension.  [electronic resource] 

 -  The European respiratory journal  Oct 2012 
 - 874-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1399-3003 
<br/><br/><label>Standard No.: </label>10.1183/09031936.00137511  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--therapeutic use<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Familial Primary Pulmonary Hypertension<br/>Female<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Male<br/>Middle Aged<br/>Pyrazines--therapeutic use<br/>Receptors, Epoprostenol<br/>Receptors, Prostaglandin--agonists<br/>Treatment Outcome<br/>Vascular Resistance--drug effects<br/>Vasodilator Agents--therapeutic use